| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.0075 | 0.8 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.0066 | 0.8 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.0081 | 0.8 |